awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35382716-7B3B9481-AC0F-434A-9172-9CF80D7B09AF
Q35382716-7B3B9481-AC0F-434A-9172-9CF80D7B09AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35382716-7B3B9481-AC0F-434A-9172-9CF80D7B09AF
Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
P2860
Q35382716-7B3B9481-AC0F-434A-9172-9CF80D7B09AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35382716-7B3B9481-AC0F-434A-9172-9CF80D7B09AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a266fec6d18d42c8e3fa754c6f6990f1518cda91
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.